| Pegaspargase studied in …STUDIED_INderived126 of 126show fewer |
|---|
| → studied in | NCT06124157Phase 2 · recruiting A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02003222Phase 3 · active not recruiting Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920737Phase 2 · active not recruiting A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04546399Phase 2 · recruiting A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959085Phase 3 · recruiting Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy · 126 trials list this drug (34 active) | — | — | Central Nervous System Leukemia,Testicular Leukemia,B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05602194Phase 3 · active not recruiting Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma · 126 trials list this drug (34 active) | — | — | Lymphoblastic Lymphoma,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05254899Phase 2 · completed A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102) · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007147Phase 3 · active not recruiting Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227584Phase 2 · recruiting ALL Backbone in AYAs · 126 trials list this drug (34 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768943Phase 2 · not yet recruiting GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400946Phase 3 · completed 05-001: Treatment of Acute Lymphoblastic Leukemia in Children · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02981628Phase 2 · active not recruiting Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914625Phase 3 · active not recruiting A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072585Phase 2/Phase 3 · not yet recruiting Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) · 126 trials list this drug (34 active) | — | — | T Lymphoblastic Leukemia/Lymphoma,T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101853Phase 3 · active not recruiting Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112916Phase 3 · active not recruiting Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Childhood T Acute Lymphoblastic Leukemia,Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01574274Phase 2 · active not recruiting SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020030Phase 3 · active not recruiting Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents · 126 trials list this drug (34 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00501826Phase 2 · recruiting Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03571321Phase 1 · recruiting Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393859Phase 3 · completed Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02553460Phase 1/Phase 2 · active not recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408005Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117751Phase 2/Phase 3 · active not recruiting Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05848687Phase 1/Phase 2 · recruiting TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883049Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations · 126 trials list this drug (34 active) | — | — | Central Nervous System Leukemia,Testicular Leukemia,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01190930Phase 3 · completed Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Childhood B Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05157971Phase 1 · active not recruiting Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05700448Phase 3 · not yet recruiting Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03808610Phase 1/Phase 2 · terminated Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07574528Phase 2 · not yet recruiting A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma · 126 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04043494Phase 3 · recruiting International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Childhood Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00558519Phase 2 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02723994Phase 2 · completed A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02881086Phase 3 · completed Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05192889Phase 1/Phase 2 · active not recruiting Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716233Phase 3 · active not recruiting A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05660473Phase 2 · recruiting Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521087Phase 1 · withdrawn A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias · 126 trials list this drug (34 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Acute Leukemia of Ambiguous Lineage+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00476190Phase 2 · completed ALL Adult Consortium Trial: Adult ALL Trial · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303821Phase 1 · completed Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03384654Phase 2 · completed A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05959720recruiting Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643276Phase 3 · recruiting Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 · 126 trials list this drug (34 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01085617completed Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03844360Phase 4 · recruiting Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease · 126 trials list this drug (34 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03792256Phase 1 · completed Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) · 126 trials list this drug (34 active) | — | — | Acute Leukemia,Lymphoblastic Lymphoma,Lymphoid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04365036Phase 3 · recruiting A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL) · 126 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02828358Phase 2 · completed Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement · 126 trials list this drug (34 active) | — | — | Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01228331Phase 2/Phase 3 · completed Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06554626Phase 2 · recruiting Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06527781Phase 1 · completed A Study of PD5K3 in Healthy Adult Volunteers · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01523977Phase 1 · completed Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00557193Phase 3 · completed Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood T Acute Lymphoblastic Leukemia,Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06210750Phase 2 · withdrawn Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) · 126 trials list this drug (34 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06376721Phase 1/Phase 2 · recruiting Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma · 126 trials list this drug (34 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381680Phase 3 · completed Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Childhood B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01186328Phase 1 · terminated EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) · 126 trials list this drug (34 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03962465Phase 1 · unknown Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL · 126 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02705508Phase 2 · unknown PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma · 126 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005585Phase 3 · completed Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005596Phase 3 · completed Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005914Phase 2 · terminated Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03349281Phase 1 · completed Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01700946Phase 2 · completed Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma · 126 trials list this drug (34 active) | — | — | Childhood B Acute Lymphoblastic Leukemia,Childhood B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01451515Phase 2 · completed NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02631239Phase 3 · unknown MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma · 126 trials list this drug (34 active) | — | — | Extranodal NK-/T-Cell Lymphoma, Nasal Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103285Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04917250Phase 2 · unknown GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075725Phase 3 · completed Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00671034Phase 3 · completed Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866307Phase 1 · completed Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00439296Phase 1/Phase 2 · terminated ABT-751 With Chemotherapy for Relapsed Pediatric ALL · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085655Phase 3 · unknown PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04676789Phase 2 · unknown Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL · 126 trials list this drug (34 active) | — | — | Extranodal NK-/T-Cell Lymphoma, Nasal Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483690Phase 1/Phase 2 · terminated A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04405375Phase 2 · unknown GPED Regimen for Relapsed/Refractory or Advanced ENKTCL · 126 trials list this drug (34 active) | — | — | Extranodal NK-/T-Cell Lymphoma, Nasal Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720109Phase 2/Phase 3 · completed Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337593Phase 2 · unknown Combination of Basiliximab and Pegaspargase in the Treatment of ENKTCL · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04096690Phase 2 · unknown Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00440726Phase 1/Phase 2 · completed Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02918747Phase 2 · unknown PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage · 126 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866749Phase 2 · completed Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03318419Phase 2 · unknown Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535806Phase 2 · terminated Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550992NA · unknown Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02518750Phase 2 · terminated Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma · 126 trials list this drug (34 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769209Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03564704Phase 2/Phase 3 · unknown Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL · 126 trials list this drug (34 active) | — | — | Leukemia,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03553238Phase 2/Phase 3 · unknown Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL · 126 trials list this drug (34 active) | — | — | Leukemia,Acute Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02419469Phase 2 · terminated Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Leukemia,Lymphoma,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02359162Phase 3 · terminated Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02533323Phase 2 · terminated P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00882206Phase 2 · terminated Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098839Phase 1/Phase 2 · completed Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) · 126 trials list this drug (34 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02825147Phase 2 · completed Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma · 126 trials list this drug (34 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01324180Phase 1 · completed Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02660762Phase 2 · unknown Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00973752Phase 2 · completed Treatment of Older Adults With Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096135NA · completed Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002744Phase 3 · completed Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873093Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 126 trials list this drug (34 active) | — | — | Adult Acute Lymphoblastic Leukemia,Adult Lymphoblastic Lymphoma,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02912702Phase 3 · unknown L-DEP as an Initial Treatment for EBV-HLH · 126 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02631109Phase 3 · unknown L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis · 126 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01991158Phase 2 · unknown GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma · 126 trials list this drug (34 active) | — | — | Extranodal NK-/T-Cell Lymphoma, Nasal Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005945Phase 3 · completed Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01225874NA · completed Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002766Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma · 126 trials list this drug (34 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01403415Phase 1 · completed Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma · 126 trials list this drug (34 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Childhood Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002590Phase 2 · completed Combination Chemotherapy in Treating Children With Lymphoma · 126 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002785Phase 2 · completed Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022737Phase 3 · completed Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022126Phase 2 · completed Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005758Phase 2 · unknown Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003437Phase 3 · unknown Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00957320Phase 1 · withdrawn Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL) · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049569NA · completed Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002812Phase 3 · completed Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343369NA · unknown Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002816Phase 3 · completed Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01921790Phase 2 · unknown Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma · 126 trials list this drug (34 active) | — | — | Extranodal NK-/T-Cell Lymphoma, Nasal Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967057Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251809Phase 1/Phase 2 · terminated Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016302NA · completed Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 126 trials list this drug (34 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890656Phase 2 · completed Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00192673Phase 4 · unknown Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses · 126 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |